Patents by Inventor Jwu-Lai Yeh

Jwu-Lai Yeh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TMD1 protein for treating bone loss diseases
    Patent number: 9775885
    Abstract: The present invention relates to a method for treating a bone loss disease, condition, or disorder in a subject in need thereof, comprising administering to said subject a pharmaceutically effective amount of a composition comprising thrombomodulin lectin-like domain (TMD1).
    Type: Grant
    Filed: January 25, 2017
    Date of Patent: October 3, 2017
    Assignee: KAOHSIUNG MEDICAL UNIVERISTY
    Inventors: Tsung-Lin Cheng, Jwu-Lai Yeh, Mei-Ling Ho, Guey-Yueh Shi, Hua-Lin Wu
  • TMD1 PROTEIN FOR TREATING BONE LOSS DISEASES
    Publication number: 20170216407
    Abstract: The present invention relates to a method for treating a bone loss disease, condition, or disorder in a subject in need thereof, comprising administering to said subject a pharmaceutically effective amount of a composition comprising thrombomodulin lectin-like domain (TMD1).
    Type: Application
    Filed: January 25, 2017
    Publication date: August 3, 2017
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Tsung-Lin Cheng, Jwu-Lai Yeh, Mei-Ling Ho, Guey-Yueh Shi, Hua-Lin Wu
  • Theophylline derivative inhibits osteoporosis
    Patent number: 8507506
    Abstract: The theophylline derivative disclosed in the present invention is characterized by having the pharmaceutical functions of osteoporosis. The theophylline derivative protects against bone resorption and inflammatory mediator infiltration.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: August 13, 2013
    Assignee: Kaohsiung Medical University
    Inventors: Jwu-Lai Yeh, Ing-Jun Chen
  • Theophylline Derivative Inhibits Osteoporosis
    Publication number: 20120184570
    Abstract: The theophylline derivative disclosed in the present invention is characterized by having the pharmaceutical functions of osteoporosis. The theophylline derivative protects against bone resorption and inflammatory mediator infiltration.
    Type: Application
    Filed: July 8, 2011
    Publication date: July 19, 2012
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Jwu-Lai Yeh, Ing-Jun Chen
  • ANTI-INFLAMMATION ACTIVITY OF NEWLY SYNTHESIZED XANTHINE DERIVATIVES KMUP-1 AND KMUP-3
    Publication number: 20090209560
    Abstract: An anti-inflammation substrate for decreasing the proinflammation induced by the cytokines and inhibiting the lung function degeneration is provided. The anti-inflammation substrate includes one selected from the group consisting of a 7-[2-[4-(2-chlorobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine, a 7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine, a respective pharmaceutical acceptable salt thereof, and a combination thereof.
    Type: Application
    Filed: April 24, 2009
    Publication date: August 20, 2009
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Ing-Jun Chen, Bin-Nan Wu, Jwu-Lai Yeh
  • ANTI-INFLAMMATION ACTIVITY OF NEWLY SYNTHESIZED XANTHINE DERIVATIVES KMUP-1 AND KMUP-3
    Publication number: 20080081816
    Abstract: An anti-inflammation substrate for decreasing the proinflammation induced by the cytokines and inhibiting the lung function degeneration is provided. The anti-inflammation substrate includes one selected from the group consisting of a 7-[2-[4-(2-chlorobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine, a 7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine, a respective pharmaceutical acceptable salt thereof, and a combination thereof.
    Type: Application
    Filed: October 3, 2006
    Publication date: April 3, 2008
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Ing-Jun Chen, Bin-Nan Wu, Jwu-Lai Yeh
  • Synthesis of capsacin derivatives and their use as an analgesic drug and vessel dilation drug
    Patent number: 5094782
    Abstract: Nonanoyl vanillylamide succinate was synthesized from synthetic capsaicin (nonanoyl vanillylamide) and succinic anhydride. The antinociceptive and cardiovascular effects of nonanoyl vanillylamide and its derivatives were investigated. We found that nonanoyl vanillylamide and nonanoyl vanillylamide succinate strongly inhibited the writhing response, led to the vascular smooth muscle relaxation, produces bradycardia and a fall of blood pressure. The potency of nonanoyl vanillylamide succinate was found to be slight greater than that of nonanoyl vanillylamide, when compared with the same molar dose/kg of their administrations.
    Type: Grant
    Filed: December 24, 1990
    Date of Patent: March 10, 1992
    Assignee: National Science Council of Republic of China
    Inventors: Chen, Jwu-Lai Yeh